How Distressing is Attendance for Routine Breast Screening

L G Walker, C M Cordiner, Fiona Jane Gilbert, Gillian Needham, H E Deans, I R Affleck, D B Hood, D Mathieson, A K Ahsee, O Eremin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

A prospective cohort study of 2357 women eligible for participation in the UK National Breast Screening Programme was carried out to evaluate the immediate emotional and behavioural effects of attending for routine mammography. Women completed the Hospital Anxiety and Depression Scale (HADS) in the context of a survey by their General Practitioner before they knew they were to receive an invitation to attend screening and again at screening some 6 weeks later. In addition, an ad hoc Health Questionnaire was administered when the women attended for screening to assess possible self-perceived stress-related behaviour changes in the previous week.

2110 (89.5% response rate) women returned the initial postal baseline HADS and 1635 completed the HADS again at screening. Anxiety and depression scales were significantly lower at screening than at baseline (t = 3.16, p < 0.002, 95% CI = 0.07 to 0.31) and (t = 8.46, p < 0.0001, 95% CI = 0.32 to 0.52) respectively. Women scoring in the borderline range at baseline were more likely to move into the normal than the clinically significant range for anxiety (chi2 = 40.36, p < 0.001) and also for depression (chi2 = 56.04, p < 0.001), and women scoring in the clinically significant range for anxiety were more likely to become normal than vice versa (chi2 = 5.95, p < 0.02). The Health Questionnaire indicated that some women reported stress-related behaviour changes in the week prior to screening, especially those who were most anxious or depressed.

Original languageEnglish
Pages (from-to)299-304
Number of pages6
JournalPsycho-Oncology
Volume3
Issue number4
Publication statusPublished - Dec 1994

Keywords

  • PSYCHIATRIC MORBIDITY
  • PSYCHOLOGICAL COSTS
  • CANCER
  • Psychiatric Morbidity
  • Pyschological Costs
  • Cancer

Cite this

Walker, L. G., Cordiner, C. M., Gilbert, F. J., Needham, G., Deans, H. E., Affleck, I. R., ... Eremin, O. (1994). How Distressing is Attendance for Routine Breast Screening. Psycho-Oncology, 3(4), 299-304.

How Distressing is Attendance for Routine Breast Screening. / Walker, L G ; Cordiner, C M ; Gilbert, Fiona Jane; Needham, Gillian; Deans, H E ; Affleck, I R ; Hood, D B ; Mathieson, D ; Ahsee, A K ; Eremin, O .

In: Psycho-Oncology, Vol. 3, No. 4, 12.1994, p. 299-304.

Research output: Contribution to journalArticle

Walker, LG, Cordiner, CM, Gilbert, FJ, Needham, G, Deans, HE, Affleck, IR, Hood, DB, Mathieson, D, Ahsee, AK & Eremin, O 1994, 'How Distressing is Attendance for Routine Breast Screening', Psycho-Oncology, vol. 3, no. 4, pp. 299-304.
Walker LG, Cordiner CM, Gilbert FJ, Needham G, Deans HE, Affleck IR et al. How Distressing is Attendance for Routine Breast Screening. Psycho-Oncology. 1994 Dec;3(4):299-304.
Walker, L G ; Cordiner, C M ; Gilbert, Fiona Jane ; Needham, Gillian ; Deans, H E ; Affleck, I R ; Hood, D B ; Mathieson, D ; Ahsee, A K ; Eremin, O . / How Distressing is Attendance for Routine Breast Screening. In: Psycho-Oncology. 1994 ; Vol. 3, No. 4. pp. 299-304.
@article{81dea84f99934465a941c52a1cff8a03,
title = "How Distressing is Attendance for Routine Breast Screening",
abstract = "A prospective cohort study of 2357 women eligible for participation in the UK National Breast Screening Programme was carried out to evaluate the immediate emotional and behavioural effects of attending for routine mammography. Women completed the Hospital Anxiety and Depression Scale (HADS) in the context of a survey by their General Practitioner before they knew they were to receive an invitation to attend screening and again at screening some 6 weeks later. In addition, an ad hoc Health Questionnaire was administered when the women attended for screening to assess possible self-perceived stress-related behaviour changes in the previous week.2110 (89.5{\%} response rate) women returned the initial postal baseline HADS and 1635 completed the HADS again at screening. Anxiety and depression scales were significantly lower at screening than at baseline (t = 3.16, p < 0.002, 95{\%} CI = 0.07 to 0.31) and (t = 8.46, p < 0.0001, 95{\%} CI = 0.32 to 0.52) respectively. Women scoring in the borderline range at baseline were more likely to move into the normal than the clinically significant range for anxiety (chi2 = 40.36, p < 0.001) and also for depression (chi2 = 56.04, p < 0.001), and women scoring in the clinically significant range for anxiety were more likely to become normal than vice versa (chi2 = 5.95, p < 0.02). The Health Questionnaire indicated that some women reported stress-related behaviour changes in the week prior to screening, especially those who were most anxious or depressed.",
keywords = "PSYCHIATRIC MORBIDITY, PSYCHOLOGICAL COSTS, CANCER, Psychiatric Morbidity, Pyschological Costs, Cancer",
author = "Walker, {L G} and Cordiner, {C M} and Gilbert, {Fiona Jane} and Gillian Needham and Deans, {H E} and Affleck, {I R} and Hood, {D B} and D Mathieson and Ahsee, {A K} and O Eremin",
year = "1994",
month = "12",
language = "English",
volume = "3",
pages = "299--304",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - How Distressing is Attendance for Routine Breast Screening

AU - Walker, L G

AU - Cordiner, C M

AU - Gilbert, Fiona Jane

AU - Needham, Gillian

AU - Deans, H E

AU - Affleck, I R

AU - Hood, D B

AU - Mathieson, D

AU - Ahsee, A K

AU - Eremin, O

PY - 1994/12

Y1 - 1994/12

N2 - A prospective cohort study of 2357 women eligible for participation in the UK National Breast Screening Programme was carried out to evaluate the immediate emotional and behavioural effects of attending for routine mammography. Women completed the Hospital Anxiety and Depression Scale (HADS) in the context of a survey by their General Practitioner before they knew they were to receive an invitation to attend screening and again at screening some 6 weeks later. In addition, an ad hoc Health Questionnaire was administered when the women attended for screening to assess possible self-perceived stress-related behaviour changes in the previous week.2110 (89.5% response rate) women returned the initial postal baseline HADS and 1635 completed the HADS again at screening. Anxiety and depression scales were significantly lower at screening than at baseline (t = 3.16, p < 0.002, 95% CI = 0.07 to 0.31) and (t = 8.46, p < 0.0001, 95% CI = 0.32 to 0.52) respectively. Women scoring in the borderline range at baseline were more likely to move into the normal than the clinically significant range for anxiety (chi2 = 40.36, p < 0.001) and also for depression (chi2 = 56.04, p < 0.001), and women scoring in the clinically significant range for anxiety were more likely to become normal than vice versa (chi2 = 5.95, p < 0.02). The Health Questionnaire indicated that some women reported stress-related behaviour changes in the week prior to screening, especially those who were most anxious or depressed.

AB - A prospective cohort study of 2357 women eligible for participation in the UK National Breast Screening Programme was carried out to evaluate the immediate emotional and behavioural effects of attending for routine mammography. Women completed the Hospital Anxiety and Depression Scale (HADS) in the context of a survey by their General Practitioner before they knew they were to receive an invitation to attend screening and again at screening some 6 weeks later. In addition, an ad hoc Health Questionnaire was administered when the women attended for screening to assess possible self-perceived stress-related behaviour changes in the previous week.2110 (89.5% response rate) women returned the initial postal baseline HADS and 1635 completed the HADS again at screening. Anxiety and depression scales were significantly lower at screening than at baseline (t = 3.16, p < 0.002, 95% CI = 0.07 to 0.31) and (t = 8.46, p < 0.0001, 95% CI = 0.32 to 0.52) respectively. Women scoring in the borderline range at baseline were more likely to move into the normal than the clinically significant range for anxiety (chi2 = 40.36, p < 0.001) and also for depression (chi2 = 56.04, p < 0.001), and women scoring in the clinically significant range for anxiety were more likely to become normal than vice versa (chi2 = 5.95, p < 0.02). The Health Questionnaire indicated that some women reported stress-related behaviour changes in the week prior to screening, especially those who were most anxious or depressed.

KW - PSYCHIATRIC MORBIDITY

KW - PSYCHOLOGICAL COSTS

KW - CANCER

KW - Psychiatric Morbidity

KW - Pyschological Costs

KW - Cancer

M3 - Article

VL - 3

SP - 299

EP - 304

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 4

ER -